Clinical
RSSArticles
-
Two Thumbs Down for COPD Screening
The U.S. Preventive Services Task Force recommends against screening asymptomatic adults for COPD.
-
Improvements in Pain and Physical Function After Bariatric Surgery
Meaningful improvements in physical function and disability due to joint pain occur promptly and are durable through at least three years of follow-up.
-
Glucose Variability in T2DM: Ready for Prime Time?
While not yet a tool for routine practice, analysis of glucose variability appears to hold promise for the future.
-
FDA Actions
Agency approves first biosimilar for infliximab, issues warning about Abilify, announces brand name change for Brintellix, greenlights pimavanserin, and brings to market first generic version of rosuvastatin.
-
Clinical Brief Notes
Researchers make progress on Ebola vaccine and diabetes treatments.
-
Study Scrutinizes Smoking Cessation Drug Risk
The neuropsychiatric risks of smoking cessation drugs may have been overstated, according to an FDA-requested study.
-
Review of Antibiotic Prescriptions Reignites Call for More Stewardship Programs
About one-third of outpatient antibiotic prescriptions may be inappropriate, according to a new study.
-
ECG Review: SVT in a 13-Year-Old Patient
The ECG in the figure below was obtained from an otherwise healthy 13-year-old boy. He was alert and hemodynamically stable at the time this ECG was recorded. How should one interpret this tracing?
-
Clinical Briefs
In this section: comparing blood pressure monitoring techniques; DPP4 agents and heart failure; identifying at-risk groups for hypoglycemia.
-
Infliximab-dyyb for Injection (Inflectra)
Infliximab-dyyb offers another, possibly less expensive, option for treatment of a number of autoimmune conditions.